Please login to the form below

Not currently logged in

FDA approves new version of diabetes drug

Japanese pharmaceutical company Daiichi Sankyo's diabetes treatment Welchol has been approved in a new formulation by the US Food and Drug Administration

Japanese pharmaceutical company Daiichi Sankyo has received US Food and Drug Administration (FDA) approval for a new formulation of its liquid diabetes drug Welchol that can be mixed with fruit juice and diet sodas.

Welchol was first approved in 2009 and was to be mixed with water. The drug lowers blood sugar in patients diagnosed with type 2 diabetes.

Meanwhile Daiichi Sankyo is replacing its legacy, on-premise customer relationship management (CRM) system with Veeva CRM in the UK. The company will deploy Veeva CRM to all of its commercial teams in the UK.

Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, Veeva customers benefit from free, automatic upgrades. Changes can be made to the system without user retraining or additional third-party costs.

26th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...